Prevalence of ANGPTL3 and APOB Gene Mutations in Subjects With Combined Hypolipidemia
Author(s) -
Davide Noto,
Angelo B. Cefalù,
Vincenza Valenti,
Francesca Fayer,
Enrico Pinotti,
M. Ditta,
Rossella Spina,
Giovanni Battista Vigna,
Pin Yue,
Sekar Kathiresan,
Patrizia Tarugi,
Maurizio Averna
Publication year - 2012
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.111.238766
Subject(s) - medicine , apolipoprotein b , endocrinology , cholesterol , heterozygote advantage , missense mutation , phenotype , genetics , gene , biology , allele
Mutations of the ANGPTL3 gene have been associated with a novel form of primary hypobetalipoproteinemia, the combined hypolipidemia (cHLP), characterized by low total cholesterol and low HDL-cholesterol levels. The aim of this work is to define the role of ANGPTL3 gene as determinant of the combined hypolipidemia phenotype in 2 large cohorts of 913 among American and Italian subjects with primary hypobetalipoproteinemia (total cholesterol<5th percentile).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom